Sleep-disordered breathing, or SDB, is a common disorder, afflicting at least 25 million adults in the United States. Similarly, more than one-third of adult Americans do not get sufficient sleep. Both conditions contribute to adverse health consequences, including daytime sleepiness and hypertension. Unfortunately, improving outcomes for patients with SDB remains an elusive goal despite the use of positive-airway pressure, or PAP, therapy. Insufficient sleep may be a confounding factor that could explain the failure to demonstrate improved outcomes with PAP therapy.
A team of nationally renowned investigators, led by Safwan Badr, M.D., M.B.A., chair and the Liborio Tranchida, M.D., Endowed Professor of Internal Medicine at Wayne State University, and Jennifer Martin, Ph.D., professor of Medicine at the David Geffen School of Medicine at the University of California – Los Angeles, will use a new five-year, $3,479,967 grant from the National Institutes of Health to investigate improved management of patients with SDB. The two are co-principal investigators of the study, “Improving outcomes for patients with SDB and insufficient sleep.”